TREA

79383436 - JAQBO

Follow

Information

  • Trademark
  • 79383436
  • Serial Number
    79383436
  • Registration Number
    7592609
  • Filing Date
    September 14, 2023
    a year ago
  • Registration Date
    December 10, 2024
    5 months ago
  • Transaction Date
    May 16, 2025
    19 days ago
  • Status Date
    December 10, 2024
    5 months ago
  • Published for Opposition Date
    October 08, 2024
    7 months ago
  • Location Date
    December 09, 2024
    5 months ago
  • Status Code
    700
  • Current Location
    FILE REPOSITORY (FRANCONIA)
    Employee Name
    ABID, NABEELA
  • Attorney Name
    John M. Kim
  • Owners
Information
Mark Drawing Code
4
Mark Identification
JAQBO
Case File Statements
  • GS0051: Veterinary pharmaceutical preparations for the treatment of gastroesophageal reflux disease, peptic ulcer, intestinal disorders, gastrointestinal disorders, erosive esophagitis, gastritis, gastric ulcer, duodenal ulcer, non-erosive reflux disease, duodenal ulcer recurrence and pathological hypersecretory conditions, and Zollinger-Ellison syndrome, and combination antibiotic therapy being antibiotics for the treatment of Helicobacter pylori infection; pharmaceutical agents affecting digestive organs; medicines for treating intestinal disorders; proton-pump inhibitor, namely, medicines for the treatment of gastroesophageal reflux disease, peptic ulcer, intestinal disorders, gastrointestinal disorders, erosive esophagitis, gastritis, gastric ulcer, duodenal ulcer, non-erosive reflux disease, duodenal ulcer recurrence and pathological hypersecretory conditions, and Zollinger-Ellison syndrome, and combination antibiotic therapy being antibiotics for the treatment of Helicobacter pylori infection; medicines for the prevention and treatment of gastrointestinal diseases; medicines for the treatment of gastrointestinal diseases; medicines for human purposes, namely, medicinal preparations for the treatment of gastroesophageal reflux disease, peptic ulcer, intestinal disorders, gastrointestinal disorders, erosive esophagitis, gastritis, gastric ulcer, duodenal ulcer, non-erosive reflux disease, duodenal ulcer recurrence and pathological hypersecretory conditions, and Zollinger-Ellison syndrome, and combination antibiotic therapy being antibiotics for the treatment of Helicobacter pylori infection; pharmaceutical preparations for the treatment of gastroesophageal reflux disease, peptic ulcer, intestinal disorders, gastrointestinal disorders, erosive esophagitis, gastritis, gastric ulcer, duodenal ulcer, non-erosive reflux disease, duodenal ulcer recurrence and pathological hypersecretory conditions, and Zollinger-Ellison syndrome, and combination antibiotic therapy being antibiotics for the treatment of Helicobacter pylori infection; ethical medicinal preparations, namely, medicinal preparations for the treatment of gastroesophageal reflux disease, peptic ulcer, intestinal disorders, gastrointestinal disorders, erosive esophagitis, gastritis, gastric ulcer, duodenal ulcer, non-erosive reflux disease, duodenal ulcer recurrence and pathological hypersecretory conditions, and Zollinger-Ellison syndrome, and combination antibiotic therapy being antibiotics for the treatment of Helicobacter pylori infection
Case File Event Statements
  • 11/16/2023 - a year ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 11/20/2023 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 11/24/2023 - a year ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 5/9/2024 - a year ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/9/2024 - a year ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 5/10/2024 - a year ago
    7 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 5/10/2024 - a year ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 6/11/2024 - 11 months ago
    8 - REFUSAL PROCESSED BY IB Type: RFNT
  • 7/30/2024 - 10 months ago
    10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/30/2024 - 10 months ago
    11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 9/3/2024 - 9 months ago
    16 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 7/30/2024 - 10 months ago
    9 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 9/3/2024 - 9 months ago
    13 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 9/3/2024 - 9 months ago
    12 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 9/3/2024 - 9 months ago
    15 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 9/3/2024 - 9 months ago
    14 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 10/8/2024 - 7 months ago
    18 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 10/8/2024 - 7 months ago
    19 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 9/18/2024 - 8 months ago
    17 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 12/10/2024 - 5 months ago
    20 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 12/10/2024 - 5 months ago
    21 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 3/10/2025 - 2 months ago
    22 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 4/15/2025 - a month ago
    24 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 5/3/2025 - a month ago
    25 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 5/15/2025 - 20 days ago
    27 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 5/15/2025 - 20 days ago
    26 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 4/15/2025 - a month ago
    23 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR